Background—Little is known about the impact of hospitalization for an acute myocardial infarction (AMI) on subsequent adherence to statins. Methods and Results—Using administrative claims from a 5% random sample of Medicare beneficiaries, we identified a cohort of Medicare patients aged ≥65 years, hospitalized from 2007 to 2011, taking statins in the year before AMI hospitalization (n=6618). We then determined the proportion of patients nonadherent to statins (proportion of days covered <80%) in the year before AMI hospitalization who became statin adherent (proportion of days covered ≥80%) in the year after AMI hospitalization. The proportion of statin-adherent patients who became nonadherent was also studied. These proportions were compa...
Background: The evidence of adherence to statin decreasing risk of major adverse cardiovascular even...
PURPOSE Secondary medication prevention after acute myocardial infarction (MI) is strongly recommen...
Prescription and adherence to statin treatment hold distinct but complementary roles in the benefici...
BACKGROUND: Hospitalizations for acute myocardial infarctions (AMIs) are associated with changes in ...
Background Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB), be...
AIMS: Experiencing an acute myocardial infarction (AMI) is a life-threatening event and use of stati...
Background—Incident cancer diagnosis may increase the risk of coronary artery disease (CAD)–related ...
Objective: To investigate long-term adherence to guideline-recommended cardioprotective medications ...
Background-—Patients with coronary heart disease are recommended to use statins following hospital d...
Objectives: To examine associations between statin adherence and lipid target achievement in myocard...
none9noPURPOSE: Clinical trials have shown that evidence-based secondary prevention medications redu...
Background: To examine the impact of cardiac- and noncardiac-related conditions on the risk of hospi...
Patient long-term adherence to β-blockers, HMG-CoA reductase inhibitors (statins), and angiotensin-c...
Aims: To investigate the 'real world' effectiveness of robust statin therapy, focusing on the effect...
Abstract Background The evidence of adherence to statin decreasing risk of major adverse cardiovascu...
Background: The evidence of adherence to statin decreasing risk of major adverse cardiovascular even...
PURPOSE Secondary medication prevention after acute myocardial infarction (MI) is strongly recommen...
Prescription and adherence to statin treatment hold distinct but complementary roles in the benefici...
BACKGROUND: Hospitalizations for acute myocardial infarctions (AMIs) are associated with changes in ...
Background Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB), be...
AIMS: Experiencing an acute myocardial infarction (AMI) is a life-threatening event and use of stati...
Background—Incident cancer diagnosis may increase the risk of coronary artery disease (CAD)–related ...
Objective: To investigate long-term adherence to guideline-recommended cardioprotective medications ...
Background-—Patients with coronary heart disease are recommended to use statins following hospital d...
Objectives: To examine associations between statin adherence and lipid target achievement in myocard...
none9noPURPOSE: Clinical trials have shown that evidence-based secondary prevention medications redu...
Background: To examine the impact of cardiac- and noncardiac-related conditions on the risk of hospi...
Patient long-term adherence to β-blockers, HMG-CoA reductase inhibitors (statins), and angiotensin-c...
Aims: To investigate the 'real world' effectiveness of robust statin therapy, focusing on the effect...
Abstract Background The evidence of adherence to statin decreasing risk of major adverse cardiovascu...
Background: The evidence of adherence to statin decreasing risk of major adverse cardiovascular even...
PURPOSE Secondary medication prevention after acute myocardial infarction (MI) is strongly recommen...
Prescription and adherence to statin treatment hold distinct but complementary roles in the benefici...